QuadraMed Wins Decision Support Contract From NewYork-Presbyterian Hospital
September 14 2006 - 4:33PM
Business Wire
QuadraMed(R) Corporation (Amex:QD) today announced that
NewYork-Presbyterian Hospital (NYP), New York, NY, has awarded the
company a contract to implement the QuadraMed Clinical Outcome
Practice Evaluator (COPE) on three of its campuses. QuadraMed COPE
is a Core Measures Reporting and decision support solution. Core
Measures are data hospitals collect about acute myocardial
infarction, heart failure, pregnancy and related conditions,
pneumonia, and surgical infection prevention. These data must then
be submitted to JCAHO (Joint Commission on Accreditation of
Healthcare Organizations) and CMS (Centers for Medicare &
Medicaid Services) to prove provider organizations meet the
requirements of the National Hospital Quality Measures initiative.
QuadraMed COPE enables the accurate and timely submission of Core
Measures data. It also combines software and professional services
that will provide NYP management with an improved decision support
solution. Using the advanced data collection methodology and
in-depth reporting capabilities of QuadraMed COPE, NYP will be able
to gain greater insight to the core quality performance of its
individual facilities, as well as an aggregate for the enterprise.
These management tools are designed to provide the decision support
that can help to further enhance a hospital's quality of care.
"NewYork-Presbyterian has long been recognized for its consistently
high quality patient care," said NYP Vice President and Chief
Quality Officer, Dr. Mary R. Cooper. "To raise our standards even
higher, we need the ability to accurately measure our performance.
COPE technology is one of the tools we are using to gather data
about the quality of care we provide. Such information is critical
for improving patient safety and outcomes." NewYork-Presbyterian
Hospital, a 2,268-bed multi-facility institution serving the New
York metropolitan area, is nationally acclaimed for providing the
highest quality patient care. It is one of only 14 hospitals named
to the "Honor Roll" of the prestigious 2006 U.S. News & World
Report guide to "America's Best Hospitals". QuadraMed has over 20
years of experience processing hospital patient-level data for
regulatory reporting and employs a COPE decision support team of
industry experts in the areas of data quality, statistics, and
healthcare financial and clinical information. The COPE solution
works in conjunction with QuadraMed's Care-Based Revenue Cycle(TM)
process to play an important role in the company's strategic
initiatives to leverage quality care into reimbursement,
interoperability for the connected healthcare community, and
quality measurement. The Website for NewYork-Presbyterian Hospital
can be found at www.nyp.org. For information about all QuadraMed
products and services, visit www.quadramed.com or call
800-393-0278. About NewYork-Presbyterian Hospital
NewYork-Presbyterian Hospital is the largest not-for-profit,
non-sectarian hospital in the country. It provides state-of-the-art
inpatient, ambulatory, and preventive care in all areas of medicine
at five major centers: NewYork-Presbyterian Hospital/Columbia
University Medical Center, NewYork-Presbyterian Hospital/Weill
Cornell Medical Center, Morgan Stanley Children's Hospital of
NewYork-Presbyterian, the Allen Pavilion, and the Westchester
Division. It consistently ranks as one of the top hospitals in the
country in U.S. News & World Report's guide to "America's Best
Hospitals." The NewYork-Presbyterian Healthcare System--an
affiliation of acute-care and community hospitals, long-term care
facilities, ambulatory sites, and specialty institutes--serves one
in four patients in the New York metropolitan area. www.nyp.org.
About QuadraMed Corporation QuadraMed Corporation advances the
success of healthcare organizations through IT solutions that
leverage quality care into positive financial outcomes. As evolving
reimbursement scenarios challenge healthcare organizations to
leverage quality of care into payment, clients committing to
QuadraMed's care-based solutions can realize market leading
financial performance. Using QuadraMed's end-to-end solutions to
optimize the patient experience and leverage quality of care into
payment, our clients can receive the proper reimbursement, in the
shortest time, at the lowest administrative cost. Behind our
products and services is a staff of almost 600 professionals whose
experience and dedication to service have earned QuadraMed the
trust and loyalty of customers at approximately 2,000 healthcare
provider facilities. To find out more about QuadraMed, visit
www.quadramed.com. Cautionary Statement on Risks Associated with
QuadraMed's Forward-Looking Statements This press release contains
forward-looking statements, as defined in Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934, by QuadraMed that are subject to risks and
uncertainties. The words "believe," "expect," "anticipate,"
"intend," "plan," "estimate," "may," "should," "could," and similar
expressions are intended to identify such statements.
Forward-looking statements are not guarantees of future performance
and are to be interpreted only as of the date on which they are
made. QuadraMed undertakes no obligation to update or revise any
forward-looking statement except as required by law. QuadraMed
advises investors that it discusses risk factors and uncertainties
that could cause QuadraMed's actual results to differ from
forward-looking statements in its periodic reports filed with the
Securities and Exchange Commission ("SEC"). QuadraMed's SEC filings
can be accessed through the Investor Relations section of our
website, www.quadramed.com, or through the SEC's EDGAR Database at
www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833). QuadraMed is
a registered trademark of QuadraMed Corporation. Care-Based Revenue
Cycle is a trademark of QuadraMed Corporation. All other trademarks
are the property of their respective holders.
Quadramed (AMEX:QD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Quadramed (AMEX:QD)
Historical Stock Chart
From Jul 2023 to Jul 2024